Year |
Citation |
Score |
2024 |
Kim M, Gorelick AN, Vàzquez-García I, Williams MJ, Salehi S, Shi H, Weiner AC, Ceglia N, Funnell T, Park T, Boscenco S, O'Flanagan CH, Jiang H, Grewal D, Tang C, ... ... Gammage PA, et al. Single-cell mtDNA dynamics in tumors is driven by coregulation of nuclear and mitochondrial genomes. Nature Genetics. PMID 38741018 DOI: 10.1038/s41588-024-01724-8 |
0.55 |
|
2024 |
Mahmood M, Liu EM, Shergold AL, Tolla E, Tait-Mulder J, Huerta-Uribe A, Shokry E, Young AL, Lilla S, Kim M, Park T, Boscenco S, Manchon JL, Rodríguez-Antona C, Walters RC, ... ... Gammage PA, et al. Mitochondrial DNA mutations drive aerobic glycolysis to enhance checkpoint blockade response in melanoma. Nature Cancer. PMID 38286828 DOI: 10.1038/s43018-023-00721-w |
0.812 |
|
2023 |
Mahmood M, Liu EM, Shergold AL, Tolla E, Tait-Mulder J, Uribe AH, Shokry E, Young AL, Lilla S, Kim M, Park T, Manchon JL, Rodríguez-Antona C, Walters RC, Springett RJ, ... ... Gammage PA, et al. Tumour mitochondrial DNA mutations drive aerobic glycolysis to enhance checkpoint blockade. Biorxiv : the Preprint Server For Biology. PMID 36993533 DOI: 10.1101/2023.03.21.533091 |
0.822 |
|
2023 |
Shaw AM, Gammage PA. Coupling Differential Centrifugation with Exonuclease Treatment and Size Exclusion Chromatography (DIFSEC) for Purification of mtDNA from Mammalian Cells. Methods in Molecular Biology (Clifton, N.J.). 2615: 31-40. PMID 36807782 DOI: 10.1007/978-1-0716-2922-2_3 |
0.582 |
|
2022 |
Kim M, Mahmood M, Reznik E, Gammage PA. Mitochondrial DNA is a major source of driver mutations in cancer. Trends in Cancer. PMID 36041967 DOI: 10.1016/j.trecan.2022.08.001 |
0.842 |
|
2021 |
Gorelick AN, Kim M, Chatila WK, La K, Hakimi AA, Berger MF, Taylor BS, Gammage PA, Reznik E. Respiratory complex and tissue lineage drive recurrent mutations in tumour mtDNA. Nature Metabolism. PMID 33833465 DOI: 10.1038/s42255-021-00378-8 |
0.579 |
|
2020 |
Jackson CB, Turnbull DM, Minczuk M, Gammage PA. Therapeutic Manipulation of mtDNA Heteroplasmy: A Shifting Perspective. Trends in Molecular Medicine. 26: 698-709. PMID 32589937 DOI: 10.1016/J.Molmed.2020.02.006 |
0.855 |
|
2020 |
Bacman SR, Gammage PA, Minczuk M, Moraes CT. Manipulation of mitochondrial genes and mtDNA heteroplasmy. Methods in Cell Biology. 155: 441-487. PMID 32183972 DOI: 10.1016/Bs.Mcb.2019.12.004 |
0.848 |
|
2019 |
Andreazza S, Samstag CL, Sanchez-Martinez A, Fernandez-Vizarra E, Gomez-Duran A, Lee JJ, Tufi R, Hipp MJ, Schmidt EK, Nicholls TJ, Gammage PA, Chinnery PF, Minczuk M, Pallanck LJ, Kennedy SR, et al. Mitochondrially-targeted APOBEC1 is a potent mtDNA mutator affecting mitochondrial function and organismal fitness in Drosophila. Nature Communications. 10: 3280. PMID 31337756 DOI: 10.1038/S41467-019-10857-Y |
0.838 |
|
2019 |
Gammage PA, Frezza C. Mitochondrial DNA: the overlooked oncogenome? Bmc Biology. 17: 53. PMID 31286943 DOI: 10.1186/S12915-019-0668-Y |
0.722 |
|
2019 |
Hoitzing H, Gammage PA, Haute LV, Minczuk M, Johnston IG, Jones NS. Energetic costs of cellular and therapeutic control of stochastic mitochondrial DNA populations. Plos Computational Biology. 15: e1007023. PMID 31242175 DOI: 10.1371/Journal.Pcbi.1007023 |
0.779 |
|
2018 |
Gammage PA, Viscomi C, Simard ML, Costa ASH, Gaude E, Powell CA, Van Haute L, McCann BJ, Rebelo-Guiomar P, Cerutti R, Zhang L, Rebar EJ, Zeviani M, Frezza C, Stewart JB, et al. Genome editing in mitochondria corrects a pathogenic mtDNA mutation in vivo. Nature Medicine. PMID 30250142 DOI: 10.1038/S41591-018-0165-9 |
0.848 |
|
2018 |
McCann BJ, Cox A, Gammage PA, Stewart JB, Zernicka-Goetz M, Minczuk M. Delivery of mtZFNs into Early Mouse Embryos. Methods in Molecular Biology (Clifton, N.J.). 1867: 215-228. PMID 30155826 DOI: 10.1007/978-1-4939-8799-3_16 |
0.848 |
|
2018 |
Gammage PA, Minczuk M. Enhanced Manipulation of Human Mitochondrial DNA Heteroplasmy In Vitro Using Tunable mtZFN Technology. Methods in Molecular Biology (Clifton, N.J.). 1867: 43-56. PMID 30155814 DOI: 10.1007/978-1-4939-8799-3_4 |
0.84 |
|
2018 |
Peeva V, Blei D, Trombly G, Corsi S, Szukszto MJ, Rebelo-Guiomar P, Gammage PA, Kudin AP, Becker C, Altmüller J, Minczuk M, Zsurka G, Kunz WS. Linear mitochondrial DNA is rapidly degraded by components of the replication machinery. Nature Communications. 9: 1727. PMID 29712893 DOI: 10.1038/S41467-018-04131-W |
0.841 |
|
2018 |
Gaude E, Schmidt C, Gammage PA, Dugourd A, Blacker T, Chew SP, Saez-Rodriguez J, O'Neill JS, Szabadkai G, Minczuk M, Frezza C. NADH Shuttling Couples Cytosolic Reductive Carboxylation of Glutamine with Glycolysis in Cells with Mitochondrial Dysfunction. Molecular Cell. 69: 581-593.e7. PMID 29452638 DOI: 10.1016/J.Molcel.2018.01.034 |
0.849 |
|
2017 |
Kullar PJ, Gomez-Duran A, Gammage PA, Garone C, Minczuk M, Golder Z, Wilson J, Montoya J, Häkli S, Kärppä M, Horvath R, Majamaa K, Chinnery PF. Heterozygous SSBP1 start loss mutation co-segregates with hearing loss and the m.1555A>G mtDNA variant in a large multigenerational family. Brain : a Journal of Neurology. PMID 29182774 DOI: 10.1093/Brain/Awx295 |
0.766 |
|
2017 |
Gammage PA, Moraes CT, Minczuk M. Mitochondrial Genome Engineering: The Revolution May Not Be CRISPR-Ized. Trends in Genetics : Tig. PMID 29179920 DOI: 10.1016/J.Tig.2017.11.001 |
0.843 |
|
2016 |
Gammage PA, Gaude E, Van Haute L, Rebelo-Guiomar P, Jackson CB, Rorbach J, Pekalski ML, Robinson AJ, Charpentier M, Concordet JP, Frezza C, Minczuk M. Near-complete elimination of mutant mtDNA by iterative or dynamic dose-controlled treatment with mtZFNs. Nucleic Acids Research. PMID 27466392 DOI: 10.1093/Nar/Gkw676 |
0.841 |
|
2016 |
Gammage PA, Van Haute L, Minczuk M. Engineered mtZFNs for Manipulation of Human Mitochondrial DNA Heteroplasmy. Methods in Molecular Biology (Clifton, N.J.). 1351: 145-62. PMID 26530680 DOI: 10.1007/978-1-4939-3040-1_11 |
0.817 |
|
2016 |
Rorbach J, Gammage PA, Minczuk M. C7orf30 is necessary for biogenesis of the large subunit of the mitochondrial ribosome. Nucleic Acids Research. 44: 992. PMID 26487634 DOI: 10.1093/Nar/Gkv1125 |
0.838 |
|
2014 |
Rorbach J, Boesch P, Gammage PA, Nicholls TJ, Pearce SF, Patel D, Hauser A, Perocchi F, Minczuk M. MRM2 and MRM3 are involved in biogenesis of the large subunit of the mitochondrial ribosome. Molecular Biology of the Cell. 25: 2542-55. PMID 25009282 DOI: 10.1091/Mbc.E14-01-0014 |
0.833 |
|
2014 |
Gammage PA, Rorbach J, Vincent AI, Rebar EJ, Minczuk M. Mitochondrially targeted ZFNs for selective degradation of pathogenic mitochondrial genomes bearing large-scale deletions or point mutations. Embo Molecular Medicine. 6: 458-66. PMID 24567072 DOI: 10.1002/Emmm.201303672 |
0.857 |
|
2013 |
Kazak L, Reyes A, Duncan AL, Rorbach J, Wood SR, Brea-Calvo G, Gammage PA, Robinson AJ, Minczuk M, Holt IJ. Alternative translation initiation augments the human mitochondrial proteome. Nucleic Acids Research. 41: 2354-69. PMID 23275553 DOI: 10.1093/Nar/Gks1347 |
0.836 |
|
2012 |
Rorbach J, Gammage PA, Minczuk M. C7orf30 is necessary for biogenesis of the large subunit of the mitochondrial ribosome. Nucleic Acids Research. 40: 4097-109. PMID 22238376 DOI: 10.1093/nar/gkr1282 |
0.833 |
|
Show low-probability matches. |